Circulating Cell-Free mtDNA Content as a Non-invasive Prognostic Biomarker in HCC Patients Receiving TACE and Traditional Chinese Medicine

Hepatocellular carcinoma (HCC) accounts for 70–85% of liver cancer, and about 85% of HCC are hepatitis B virus-related (HBV-HCC) in China. Transarterial chemoembolization (TACE) combined with traditional Chinese medicine (TCM) has been reported as an effective treatment. Potential biomarkers to stra...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Guanlin, Li, Ying, Li, Shicheng, Liu, Hongxia, Xu, Fei, Lai, Xiaohuan, Zhang, Qiong, Xu, Jingxiang, Wan, Shaogui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481798/
https://www.ncbi.nlm.nih.gov/pubmed/34603382
http://dx.doi.org/10.3389/fgene.2021.719451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481798/
https://www.ncbi.nlm.nih.gov/pubmed/34603382
http://dx.doi.org/10.3389/fgene.2021.719451

Ejemplares similares